Skip to content
2000
Volume 8, Issue 6
  • ISSN: 1570-1611
  • E-ISSN: 1875-6212

Abstract

The 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibitors (statins) are a class of drug used to lower low-density lipoprotein (LDL) levels. However, in recent years, statins have been shown to possess a pleiotropic effect beyond its cholesterol lowering ability, including attenuating the effect of ischaemia reperfusion injury. This review considers the biomolecular processes that may lead to this beneficial effect.

Loading

Article metrics loading...

/content/journals/cvp/10.2174/157016110793563780
2010-11-01
2025-10-04
Loading full text...

Full text loading...

/content/journals/cvp/10.2174/157016110793563780
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test